Cerebral Therapeutics, Inc.
Dr. Hammond is a Principal on the Investment Team at RA Capital Management. He works on both public and private investments across therapeutic areas. Dr. Hammond holds a BS in Environmental Health Science from the University of Georgia and both a PhD in Biomedical Science and an MBA in Finance from the University of Connecticut. He is currently a board observer at Akouos, Imara Therapeutics, and Imbria Pharmaceuticals. He previously served as a board observer at Calimmune, Crinetics Pharmaceuticals, Eidos Therapeutics, Precision Biosciences, Solid Biosciences, and Stoke Therapeutics.
This person is not in the org chart
This person is not in any offices
Cerebral Therapeutics, Inc.
Cerebral Therapeutics is a clinical-stage pharmaceutical company dedicated to improving the lives of patients living with uncontrolled neurological diseases, with an initial focus on refractory epilepsy.